SCHEMBL25810241

SCHEMBL25810241

CC1CN(C(=O)CN(C)C)C1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
NPC1 O15118 1/20 0.39
CHRNB2 P17787 5/20 0.39
CHRNA4 P43681 5/20 0.39
LMNA P02545 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
HPGD P15428 1/20 0.36
CHRNA3 P32297 4/20 0.35
CHRNB3 Q05901 2/20 0.35
CHRNA6 Q15825 2/20 0.35
CHRNB4 P30926 2/20 0.34
CHRNA7 P36544 2/20 0.34
RORC P51449 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12385823 0.86 ALDH1A1 (0.51) ALDH1A1NPC1LMNAKDM4EMEN1
SCHEMBL25468390 0.86 ALDH1A1 (0.51) ALDH1A1NPC1LMNAKDM4EMEN1
SCHEMBL21430362 0.81 ALDH1A1 (0.65) ALDH1A1NPC1LMNAMEN1POLB
SCHEMBL27292932 0.81 KDM4E (0.37) ALDH1A1CHRNB2CHRNA4KDM4ECHRNA3
SCHEMBL2606053 0.81 ALDH1A1 (0.62) ALDH1A1NPC1LMNAKDM4EMEN1
SCHEMBL25824934 0.79 NPC1 (0.46) ALDH1A1NPC1CHRNB2CHRNA4LMNA
SCHEMBL14873798 0.78 CHRNB2 (0.39) CHRNB2CHRNA4KDM4ECHRNA3CHRNB3
SCHEMBL18685371 0.78 CHRNB2 (0.39) CHRNB2CHRNA4KDM4ECHRNA3CHRNB3
SCHEMBL24491611 0.78 KDM4E (0.36) ALDH1A1CHRNB2CHRNA4LMNAKDM4E
SCHEMBL18685401 0.78 CHRNB2 (0.39) CHRNB2CHRNA4KDM4ECHRNA3CHRNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023235380-A1 MACROLIDES FOR TREATING GENETIC DISEASES ZIKANI THERAPEUTICS, INC. (US) 2023-12-07 WO disclosed
WO-2023125737-A1 HETEROCYCLIC COMPOUNDS AND USE THEREOF SILEXON AI TECHNOLOGY CO., LTD. (CN) 2023-07-06 WO disclosed